MedTrace Logo

A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337

NCT03382756 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2017-12-27

No results posted yet for this study

Summary

A cross-over, randomized and open-label clinical trial to evaluate the effects of food on the bioavailability of CKD-337 after a single oral dose in healthy male subjects

Conditions

  • Dyslipidemias

Interventions

DIETARY_SUPPLEMENT

High fat diet

A diet consisting of more than 900kcal and 35% of fat

DRUG

CKD-337

Test Drug

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Min Kyu Park, Professor · Dong-A University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-12
Primary Completion
2017-11-02
Completion
2017-11-07

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03382756 on ClinicalTrials.gov